Dyspepsia - Acid or stress? A study of controversy: Abandoned by experts, finalized in clinical practice?

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 11, 1999, Pages 1057-1064

  Molinder, Herdis ^a   Wallander, Mari Ann ^a   Hallberg, Margareta ^b   Bodemar, Göran ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

CLINICAL PRACTICE; DYSPEPSIA; ENDOSCOPY; ESOPHAGITIS; GASTRITIS; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; NOTE; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ACID; STOMACH ACID SECRETION; STRESS;

ANTACIDS; ANTI-ULCER AGENTS; DYSPEPSIA; GASTRIC ACID; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STRESS, PSYCHOLOGICAL;

EID: 0032743126     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750024823     Document Type: Note

References (67)

1. 1. Brante T, Norman H. Epidemisk masspsykos eller reell risk? En sociologsk studie av kontroversen kring elöverkänslighet. (Epidemic mass psychosis or a real risk? A sociologic study of the controversy on hypersensitivity against electricity.) Stockholm: Brutus Östlings Bokförlag Symposion; 1995.
2. 2-receptor antagonists to Scandinavia. Effects of experts' opinions. Scand J Gastroenterol 1998;33:224-30.
3. 3. Sjödin I. Psychotherapy in peptic ulcer disease [dissertation]. Göteborg: University of Göteborg; 1983.
4. 4. Molinder H. Scandinavian views on non surgical treatment of peptic ulcer. Stand J Gastroenterol 1995;30:721-30.
5. 5. Peterson H. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
6. 6. Adami H-O, Agenäs T, Nyrén O, Gustavsson S, Lööf L, Nyberg A. The clinical diagnosis of 'gastritis'. Scand J Gastroenterol 1984;19:216-9.
7. 7. Krag E. Pseudo-ulcer and true peptic ulcer. Acta Med Scand 1965;178(Fasc 6):713-28.
8. 8. Bendtsen F, Danö P, Guldhammer B, Remvig L, Krogsöe O. Cimetidinbehandling af rontgennegative dyspepsi. (Cimetidine therapy in radio-negative dyspepsia. English summary.) Ugeskr Laeger 1983;145:3090-3.
9. 9. Berstad A, Hausken T, Haug T. Funksjonell dyspepsi - en stressjukdom. (Functional dyspepsia - a manifestation of stress. English summary.) Tidsskr Nor Laegeforen 1992;112:1603-4.
10. 10. Nyrén O, Adami H-O, Gustavsson S, Lindgren PG, Lööf L, Nyberg A. Epigastric distress syndrome. J Clin Gastroenterol 1987;9:303-9.
11. 11. Gotthard R, Bodemar G, Brodin U, Jönsson K-Å. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988;23:7-18.
12. 12. Möller-Hansen J Dyspepsia in primary care [dissertation]. Odense: Odense University; 1996.
13. 13. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gatsroenterology 1995;109:671-80.
14. 14. Nörrelund N, Helles A, Schmiegelow M, Jacobsen F, Nielsen HOW, Kjaerulff E, et al. Ukarakteristik dyspepsi i almen praksis. (Uncharacteristic dyspepsia in general practice. English summary.) Ugeskr Laeger 1980;142:1750-3.
15. 15. Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomised double blind trial. Scand J Gastroenterol 1988;23:237-43.
16. 16. Kelbaek H, Linde J, Eriksen J, Munksgaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985;217: 281-7.
17. 17. Schaffalitsky de Muckadell O. Peptisk ulcus og ulcusdyspepsi. (Peptic ulcer and ulcer dyspepsia.) Ugeskr Laeger 1997;159: 3745.
18. 18. Nyrén O Non-ulcer dyspepsia [dissertation]. Uppsala: University of Uppsala; 1985.
19. 19. Nyrén O, Adami HO, Bates S, Bergström R, Gustavsson S, Lööf L, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986;314:339-43.
20. 20. Nyrén O, Adami HO, Gustavsson S, Lööf L. Excess sick-listing in nonulcer dyspepsia. J Clin Gastroenterol 1986;8:339-45.
21. 21. Haug T, Wilhelmsen I, Ursin H, Berstad A. What are the real problems for patients with functional dyspepsia? Scand J Gastroenterol 1995;30:97-100.
22. 22. Jörgensen LS, Bönlökke L, Christensen N. Life strain, life events, and autonomic response to a psychological stressor in patients with chronic upper abdominal pain. Scand J Gastroenterol 1986;21:605-13.
23. 23. Johnsen R, Straume B, Förde OH. Peptic ulcer and non-ulcer dyspepsia - a disease and a disorder. Scand J Prim Health Care 1988;6:239-43.
24. 24. Berstad A, Hauksen T, Gilja O, Hveem K, Underland KA, Wilhelmsen J, et al. Gastric accommodation in functional dyspepsia. Scand J Gastroenterol 1997;32:193-7.
25. 25. Haug T, Wilhelmsen I, Svebak S, Berstad A, Ursin H. Psychotherapy in functional dyspepsia. J Psychosom Res 1994; 38:735-44.
26. 26. Johannessen T. Funksjonell dyspepsi (Functional dyspepsia). Tidsskr Nor Laegefor 1992;112:1568-9.
27. 27. Tanum L, Malt UF. A new pharmacological treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996;31: 318-25.
28. 28. Gotthard R, Bodemar G, Jönsson K-Å. Diagnostic outcome in patients with dyspepsia. A preliminary report. Scand J Gastroenterol 1987;22 Suppl 128:86-9.
29. 29. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindelbesk NE, Müller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993;38:147-54.
30. 30. Nesland A, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985;20:629-35.
31. 31. Kleveland P, Larsen S, Sandvik L, Kristensen P, Johannesen T, Hafstad PE, et al. The effect of cimetidine in non ulcer dyspepsia. Experience with a multi cross-over model. Scand J Gatroentcrol 1985;20:19-24.
32. 32. Johannessen T, Fjøsne U, Kleveland P, Halvorsen T, Kristensen P, Løge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988;23:327-36.
33. 33. Farup P, Hovde Ø, Breder O. Are frequent short gastrooesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? Scand J Gastroenterol 1995;30:829-32.
34. 34. Bytzer P. Medikamentell behandling af non-ulcus dyspepsi. (Medicinal treatment of non-ulcer dyspepsia. English summary.) Ugeskr Laeger 1991;153:2212-6.
35. 35 Colin-Jones D. Management of dyspepsia. Report of a working party. Lancet 1988;1:576-9.
36. 36. Talley N, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-60.
37. 37. Möller-Hansen J, Bytzer P, Schaffalitzky de Munkatell O. Managment of dyspeptic patients in primary care. Scand J Gastroenterol 1998;33:799-805.
38. 38. Talley N, Weaver A, Tesmer D, Zinsmeister A. Lack of discriminant value of dyspepsia subgroups in patients referred tor upper endoscopy. Gastroenterology 1993;105:1378-86.
39. 39. Bytzer P, Møller-Hansen J, Schaffalitzky de Muckadell OB, Malcow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. Scand J Gastroenterol 1997;32:118-25.
40. 40. Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991;26:763-70.
41. 41. Johannessen T Controlled trials in single subjects [dissertation] Trondheim: University of Trondheim; 1992.
42. 42. Johannessen T. Controlled trials in single subjects. Br Med J 1991;303:173-4.
43. 43. Farup PG, Wetterhus S, Osnes M, Ulshagen K. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. Scand J Gastroenterol 1997;32:755-9.
44. 44. Kristensen P, Sandbakken P, Johannessen T, Løge I, Hafstad PE, Petersen H, et al. Fordøyelsessykdommer i almenpraksis. (Gastrointestinal diseases in general practice.) Tidsskr Nor Laegeforen 1985;105:728-31.
45. 45. Nyrén O, Lindberg G, Lindström E, Marke L-Å, Seensalu R. Economic costs of functional dyspepsia. Pharm Econom 1992; 1:312-24.
46. 46. Nyrén O. Treatment of non-ulcer dyspepsia. In: Thorén L, Ljunggren H, Beerman B, Lönnerholm G, editors. Pharmacological treatment of ulcer and non-ulcer dyspepsia. Uppsala: Swedish National Board of Health and Welfare. Drug Information Committee, Sweden; 1985. p. 97-109.
47. 47. Experts' group. Non-ulcer dyspepsia. In: Thorén I, Ljunggren H, Beerman B, Lönerholm G, editors. Pharmacological treatment of ulcer and non-ulcer dyspepsia. Uppsala: National Board of Health and Welfare. Drug Information Committee, Sweden; 1984. p. 160-1.
48. 48. Lindberg G, Lindström E, Marké L, Nordlund A, Nyrén O. Gatroskopi - vid utredning av ont i magen. (Gastroscopy - in investigation of abdominal pain.) Stockholm: The Swedish Council on Technology Assessment in Health Care; 1990.
49. 2 antagonists over the counter. Lancet 1992;339:418.
50. 50. Järhult B. Cimetidinbehandling i öppen vård. (Cimetidine therapy in outpatient care. English summary.) Lakartidningen 1980;77:45-8.
51. 51. Rosell A. Tagamet (cimetidin) i Arjeplog. (Tagamet (cimetidine) in Arjeplog.) Lakartidningen 1978;75:4012.
52. 52. Rosén A, Strandberg K. Tagamet och den obundna läkemedels-informationen. (Tagamet and the uncommitted information of drugs.) Lakartidningen 1978;75:4461.
53. 53. Lidén E. Undermedicin orsakar depression-njurskador (Wonderdrug causes depression and kidney-damage.) Dala-Demokraten 1978 Nov.;08:5.
54. 54. Grundström E. Varning för vanlig magsårsmedicin. (Warning against a common drug for peptic ulcer.) Dagens Nyheter 1981 Oct.;9:12.
55. 55. Nilsson M. Pillret som drabbar de svenska industriarbetarna. (The pill that hits the Swedish workers.) Metallarbetaren 1980; (11):16-8.
56. 56. Jöberger B. Mirakelmedicin mot magkatarr. (Wonder drug against gastritis.) Dagens Nyhetcr 1978 Oct.;18:3-4.
57. 57. Thürmer HL, Flaaten B, Erichsen K, Lid N, Solheim S. Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Scand J Gastroenterol 1996;31:744-8.
58. 58. Nyrén O. Functional dyspepsia: is gastric acid and/or Helicobacter pylori infection involved in the aethiology? Eur J Gastroenterol Hepatol 1992;4:608-14.
59. 59. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer A-I, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? Br Med J 1992;304:1276-79.
60. 60. Agréus L. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. Scand J Gastroenterol 1995;30:752-7.
61. 61. Bytzer P. Diagnosing dyspepsia: any controversies left? Gastroenterology 1996;110:302-6.
62. 62. Krag E. Gastro-ösofagealt reflukssyndrom. (Gastro-oesophageal reflux-syndrrome.) In: Thaysen JH, Chistensen LK, Lorenzen 1, editors. Medicinsk kompendium. Vol 1. 13th ed. Copenhagen: Nyt Nordisk Forlag; 1986. p. 1120-23.
63. 63. Joelsson B, Johnsson F. Heartburn-the acid test. Gut 1989;30: 1523-5.
64. 64. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987;22:714-8.
65. 65. Klauser A, Schindbleck N, Müller-Lissner S. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205-8.
66. 66. Nissen A. Mavesårspracparater: forbrug, priser og tilskud för og efter den 27.3.1989. (Drugs for peptic ulcer. Expenditure, prices and reimbursement before and after March 27 1989.) Ugeskr Laeger 1991;153:1536-37.
67. 67. Ahnfeldt-Møllerup I, Fly G, Knudsen MH. Dyspepsi i almen praxis. (Dyspepsia in general practice. English summary.) Ugeskr Laeger 1997;159:3772-6.